In an effort to become a profitable company sooner, Nanogen (San Diego), a developer of molecular and rapid in vitro diagnostic products, has agreed to combine its business with the Elitech Group (Paris), a private French diagnostics company, in an all-stock deal. (Medical Device Daily)